BSEBoard Meeting4d ago · 1 Aug 2026, 03:41 pm

Venmax Drugs And Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 ,inter alia, to consider and approve Unaudited ....

Venmax Drugs and Pharmaceuticals Ltd · 531015

✦ AI SummaryResults

Venmax Drugs and Pharmaceuticals Ltd has scheduled a board meeting on August 7, 2026, to consider and approve unaudited financial results for the quarter ended June 30, 2026, and to consider the forfeiture of partly paid-up share warrants.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Venmax Drugs and Pharmaceuticals Ltd - 531015 - Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended June 30, 2026.

Attachments (1)

📄

32c06f4b-ef99-4ffc-b014-dda0732e436f.pdf

pdf

Download →
View document text
August 1, 2026 The Manager Corporate Relationship Department BSE Limited Phiroze Jeejeebhoy Towers Dalal Street, Fort Mumbai – 400001 Scrip Code: 531015 Sub: Intimation of Board Meeting to be held on 07.08.2026 Dear Sir / Madam, A Meeting of the Board of Directors of the company will be held on Friday, August 7, 2026 at 4.00 P.M, inter-alia to consider the following: 1. To consider and approve the Un-audited Financial Results of the Company for the Quarter ended June 30, 2026. 2. To consider and approve the Forfeiture of partly paid-up share warrants. Further, we wish to inform you that the Trading Window for dealing in Securities of the Company which stands closed for all the Designated Persons of the Company with effect from July 1, 2026 would continue to remain closed till August 9, 2026 i.e., till 48 hours after the approval of the Un- audited Standalone Financial Results of the Company for the Quarter ended June 30, 2026. Kindly take the above information on record. Thanking You For Venmax Drugs and Pharmaceuticals Limited Priyanka Agarwal Company Secretary & Compliance Officer Reg Office: Sy. No. 115, Brig Sayeed Road, Hanumanji Colony, Bowenpally, Picket, Hyderabad – 500009 CIN: L24230TG1988PLC009102 GSTIN: 36AAACY1073C3ZM E-mail: venmaxdrugs@gmail.com